#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperoxaluria Obesity B precursor type acute leukaemia Autologous haematopoietic stem cell transplant Lupus nephritis Usher's syndrome Pemphigus Uterine leiomyosarcoma Idiopathic intracranial hypertension Hypocalcaemia Endometrial cancer recurrent Cardiac arrest Leiomyosarcoma Neuroendocrine tumour of the lung Hairy cell leukaemia More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma – Life with Disease Sjogren’s syndrome – Trials in Disease Glycogen storage disease type V – Life with Disease Paraneoplastic neurological syndrome – Treatment Chordoma Ornithine transcarbamoylase deficiency – Life with Disease X-linked lymphoproliferative syndrome Tuberous sclerosis complex – Life with Disease Gaucher’s disease type I – Diagnostics Rosai-Dorfman syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tigulixostat Prasterone Dalteparin Sodium Faricimab TEV-53408 Meropenem Trihydrate Metreleptin Sodium Butyrate Clenbuterol Hydrochloride APAZUNERSEN MAPLIRPACEPT Ucart20X22 Acetazolamide Sodium Tadekinig Alfa Istaroxime GSKVX000000034795 Pertechnetate (99Mtc) Sodium ADX-324 GUAIACOL Piritramide More therapies…

    Learn about Your Condition

    Malabsorption Pulmonary sarcoidosis Fabry's disease Vascular calcification Vasospasm Spinal pain Deafness neurosensory Myopia Periarthritis Spinal osteoarthritis Encephalitis Japanese B Lower limb fracture Mesothelioma Pseudomyxoma peritonei Hereditary angioedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hyponatraemia

  • Study on Using Desmopressin Acetate Trihydrate to Prevent Sodium Overcorrection in Patients with Severe Hyponatremia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Lactate
    • Glucose Monohydrate
    • Meglumine Gadoterate
    France

  • Study on the Effects of Empagliflozin in Patients with Euvolemic and Hypervolemic Hyponatremia

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Empagliflozin
    • Lactose Monohydrate
    Germany The Netherlands

  • Study on Urea for Treating Low Sodium Levels in Patients with Brain Hemorrhage

    Not recruiting

    2 1
    Investigated Diseases:
    • Hyponatraemia
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Urea
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!